Clinical trials
Withdrawn Phase 2 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Arbutus Biopharma Corporation | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| CSL Behring | 1 |
| ETOP IBCSG Partners Foundation | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Janssen Research & Development, LLC | 1 |
| Kezar Life Sciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 2 |
| Anemia | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Angina, Stable | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Cystic Fibrosis | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.